Skip to main content

TableĀ 3 Relationship between socio-demographics, clinical features, and pre-referral injectable artesunate among children with severe malaria

From: Pre-referral injectable artesunate and outcomes of childhood severe malaria at a secondary health facility in North-central Nigeria: a cross-sectional study

Variables

Total

n = 137

Pre-referral

Injectable artesunate, n = 7 (%)

No pre-referral injectable artesunate

n = 130

P value

Age groups [months]

Ā Ā Ā Ā 

 ≤ 12

18

1 (5.6)

17 (94.4)

0.166*

Ā 13–59

72

2 (2.8)

70 (97.2)

Ā 

 ≄ 60

47

4 (8.5)

43 (91.5)

Ā 

Father education

Ā Ā Ā Ā 

Ā No formal

5

0 (0.0)

5 (50.0)

0.067*

Ā Primary

40

5 (12.5)

35 (87.5)

Ā 

Ā Secondary

50

2 (4.0)

48 (96.0)

Ā 

Ā Tertiary

42

0 (0.0)

42 (100.0)

Ā 

Mother education

Ā Ā Ā Ā 

Ā No formal

18

3 (16.7)

15 (83.3)

0.077*

Ā Primary

31

1 (3.2)

30 (96.8)

Ā 

Ā Secondary

57

3 (5.3)

54 (94.7)

Ā 

Ā Tertiary

31

0 (0.0)

31 (100.0)

Ā 

Socio-economic class

Ā Ā Ā Ā 

Ā Upper

25

0 (0.0)

25 (100.0)

0.095*

Ā Middle

78

3 (3.8)

75 (96.2)

Ā 

Ā Lower

34

4 (11.8)

30 (88.2)

Ā 

Clinical features

Ā Ā Ā Ā 

Ā Fever

132

7 (5.3)

125 (94.7)

1.000

Ā Vomiting

54

3 (5.6)

51 (94.4)

1.000

Ā Loose stool

20

1 (100.0)

20 (0)

0.593

Ā Convulsions

43

4 (9.3)

39 (90.7)

0.205

Ā Severe anemia

79

2 (2.5)

77 (97.5)

0.113

Ā Dark urine

43

1 (0.7)

42 (97.7)

0.433

Ā Prostration

88

3 (3.4)

85 (96.6)

0.248

Ā Jaundice

2

0 (0.0)

2 (100.0)

1.000

Ā Reduce urine output

5

0 (0.0)

5 (100.0)

1.000

Ā Impair levels of consciousness

7

2 (28.2))

5 (71.4)

0.042

Symptoms duration [hours]

Ā Ā Ā Ā 

 ≤ 24

43 (31.4)

2 (4.7)

41 (95.3)

0.775*

Ā 25–72

62 (45.3)

4 (6.5)

58 (93.5)

Ā 

Ā > 72

32 (23.4)

1 (3.1)

32 (96.9)

Ā 

Hospitalisation durations [days]

Ā Ā Ā Ā 

 ≤ 1

6

0 (0.0)

6 (100.0)

0.727*

Ā 2–3

81

5 (6.2)

76 (93.8)

Ā 

Ā > 3

50

2 (4.0)

48 (96.0)

Ā 
  1. *G-test (likelihood) for Chi-square test